diethylstilbestrol and sirolimus

diethylstilbestrol has been researched along with sirolimus in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Kmoníčková, E; Peterková, L; Rimpelová, S; Ruml, T1
Albaqshi, BT; Alomary, MN; Alsaeed, WJ; Beigh, S; Gomaa, MS; Khan, FA; Pottoo, FH; Rahman, JU; Salahuddin, M; Salama, I1

Reviews

1 review(s) available for diethylstilbestrol and sirolimus

ArticleYear
Sarco/Endoplasmic Reticulum Calcium ATPase Inhibitors: Beyond Anticancer Perspective.
    Journal of medicinal chemistry, 2020, 03-12, Volume: 63, Issue:5

    Topics: Animals; Antineoplastic Agents; Enzyme Inhibitors; Gene Regulatory Networks; Humans; Neoplasms; Protein Structure, Secondary; Sarcoplasmic Reticulum Calcium-Transporting ATPases

2020

Other Studies

2 other study(ies) available for diethylstilbestrol and sirolimus

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Therapeutic enhancing potential of piracetam with diethylstilbestrol in prevention of grand-mal seizures in rats: inhibition of PI3K/Akt/mTOR signaling pathway and IL-1β, IL-6, TNF-α cytokines levels.
    European review for medical and pharmacological sciences, 2023, Volume: 27, Issue:10

    Topics: Animals; Cytokines; Diethylstilbestrol; HEK293 Cells; Humans; Interleukin-6; Pentylenetetrazole; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Piracetam; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Tumor Necrosis Factor-alpha

2023